These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 17401633)

  • 1. Prognostic factors for progression of visual field damage in patients with normal-tension glaucoma.
    Spaeth GL
    Jpn J Ophthalmol; 2007; 51(2):156; author reply 156-7. PubMed ID: 17401633
    [No Abstract]   [Full Text] [Related]  

  • 2. Prognostic factors for progression of visual field damage in patients with normal-tension glaucoma.
    Nakagami T; Yamazaki Y; Hayamizu F
    Jpn J Ophthalmol; 2006; 50(1):38-43. PubMed ID: 16453186
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pressure fluctuation.
    Caprioli J; Coleman A
    Ophthalmology; 2009 Apr; 116(4):817. PubMed ID: 19344837
    [No Abstract]   [Full Text] [Related]  

  • 4. Fluctuating intraocular pressure.
    Broadway D; Miglior S; Myers JS
    J Glaucoma; 2005 Jun; 14(3):249-51. PubMed ID: 15870610
    [No Abstract]   [Full Text] [Related]  

  • 5. Normal-tension glaucoma.
    Anderson DR; Graham S; Pillunat L
    J Glaucoma; 2003 Apr; 12(2):164-6. PubMed ID: 12671472
    [No Abstract]   [Full Text] [Related]  

  • 6. Relationship of progression of visual field damage to postural changes in intraocular pressure in patients with normal-tension glaucoma.
    Kiuchi T; Motoyama Y; Oshika T
    Ophthalmology; 2006 Dec; 113(12):2150-5. PubMed ID: 16996611
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relationship between central corneal thickness and progression of visual field loss in patients with open-angle glaucoma.
    Cao KY; Kapasi M; Betchkal JA; Birt CM
    Can J Ophthalmol; 2012 Apr; 47(2):155-8. PubMed ID: 22560421
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Continued visual field progression in eyes with prior visual field progression in patients with open-angle glaucoma.
    Chen PP; Cady RS; Mudumbai RC; Ngan R
    J Glaucoma; 2010 Dec; 19(9):598-603. PubMed ID: 20179616
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sleep position and eye pressure.
    Mehdizadeh M
    Ophthalmology; 2007 Dec; 114(12):2362; author reply 2362. PubMed ID: 18054647
    [No Abstract]   [Full Text] [Related]  

  • 10. Predictors for visual field progression.
    Harris A; Siesky B; Shoshani Y; Januleviciene I
    Acta Ophthalmol; 2010 Aug; 88(5):504-5. PubMed ID: 20653571
    [No Abstract]   [Full Text] [Related]  

  • 11. Long-term relationship between intraocular pressure and visual field loss in primary open-angle glaucoma.
    Inatani M; Iwao K; Inoue T; Awai M; Muto T; Koga T; Ogata-Iwao M; Hara R; Futa R; Tanihara H
    J Glaucoma; 2008; 17(4):275-9. PubMed ID: 18552612
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intraocular pressure and visual field progression in open-angle glaucoma.
    Kass MA; Gordon MO
    Am J Ophthalmol; 2000 Oct; 130(4):490-1. PubMed ID: 11024422
    [No Abstract]   [Full Text] [Related]  

  • 13. Intraocular pressure fluctuation a risk factor for visual field progression at low intraocular pressures in the advanced glaucoma intervention study.
    Caprioli J; Coleman AL
    Ophthalmology; 2008 Jul; 115(7):1123-1129.e3. PubMed ID: 18082889
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relation of glaucoma progression and myopia: the role of axial length.
    Nowroozzadeh M
    Eur J Ophthalmol; 2009; 19(2):327; author reply 327. PubMed ID: 19253262
    [No Abstract]   [Full Text] [Related]  

  • 15. Predictors for visual field progression and the effects of treatment with dorzolamide 2% or brinzolamide 1% each added to timolol 0.5% in primary open-angle glaucoma.
    Martínez A; Sanchez-Salorio M
    Acta Ophthalmol; 2010 Aug; 88(5):541-52. PubMed ID: 19799592
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intraocular pressure and visual field damage as risk factors for visual field progression in filtering surgery.
    Cohen JS; Novack GD; Zink JM
    Ophthalmic Surg Lasers Imaging; 2010; 41(4):452-8. PubMed ID: 20608614
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fluctuation of intraocular pressure and glaucoma progression in the early manifest glaucoma trial.
    Bengtsson B; Leske MC; Hyman L; Heijl A;
    Ophthalmology; 2007 Feb; 114(2):205-9. PubMed ID: 17097736
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Two-year randomized, placebo-controlled study of black currant anthocyanins on visual field in glaucoma.
    Ohguro H; Ohguro I; Katai M; Tanaka S
    Ophthalmologica; 2012; 228(1):26-35. PubMed ID: 22377796
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Finding risks for glaucoma.
    Brandt JD
    Arch Ophthalmol; 2008 Aug; 126(8):1138-9. PubMed ID: 18695110
    [No Abstract]   [Full Text] [Related]  

  • 20. Association between nocturnal blood pressure reduction and progression of visual field defect in patients with primary open-angle glaucoma or normal-tension glaucoma.
    Tokunaga T; Kashiwagi K; Tsumura T; Taguchi K; Tsukahara S
    Jpn J Ophthalmol; 2004; 48(4):380-5. PubMed ID: 15295667
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.